Robbins Headache Clinic Blog
“Aspirin, The Original Wonder Drug” from The New York times
Aspirin, the original wonder drug, has long been a go-to medicine for millions, a Jack-of-all trades remedy that is readily available and cheap. Championed for its ability to relieve pain, fever and inflammation, aspirin has been a staple in home medicine cabinets and...
“Migraine Treatment Delivered by Microneedle Patch Under FDA Review” from Neurology Advisor
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for Qtrypta™ (M207) (zolmitriptan intracutaneous microneedle system; Zosano Pharma) for the acute treatment of migraine. Qtrypta delivers zolmitriptan, a selective...
“Could Smartphones Be Making Migraines Even Tougher to Treat?” from Drugs.com
If you have raging headaches and you spend a lot of time on your smartphone, a new study suggests you might want to put your phone down whenever you can. Researchers found that folks who use their smartphones frequently and have headaches or migraines also tend to...
“FDA Approves Prescription Arthritis Pain Treatment for OTC Use” from healio.com/rheumatology
The FDA has approved Voltaren Arthritis Pain for nonprescription, over-the-counter use, according to a press release. Voltaren (diclofenac sodium topical gel 1%, GlaxoSmithKline), a NSAID previously available only with a prescription, is intended for the temporary...
“Stop Touching Your Face!” from The New York Times
It’s a quirk of human nature that we touch our eyes, noses and mouths all day long. It’s also a major way we pick up infections like coronavirus. Want to improve your chance of staying healthy? Stop touching your face! One of the more difficult challenges in public...
“Migraine: A History” from cbsnews.com
In the book "Migraine: A History" (Johns Hopkins University Press), medical historian Katherine Foxhall writes of a disabling disease that has been documented going back thousands of years, though the causes of this neurological disorder are still unclear. Symptoms...
“FDA Approves Nurtec ODT” from drugs.com/newdrugs.html
NEW HAVEN, Conn., Feb. 27, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the U.S. Food and Drug Administration (FDA) has approved Nurtec ODT (rimegepant) for the acute treatment of migraine in adults. Nurtec ODT is...
“Is There a Link Between Migraine and Psoriasis?” from Clinical Pain Advisor
Patients with psoriasis are at increased risk for migraines, according to a research letter published in the Journal of the American Academy of Dermatology. Researchers from the New York University School of Medicine examined data obtained from the 2003-2004 National...
“Anxious About the News?” from Medical News Today
Reading the news can be stress-inducing at the best of times. When the news is particularly worrying, many of us experience levels of anxiety so high that we can have difficulty coping. So how can we stay (reasonably) anxiety-free when the media bombards us with...
“Vyepti: First Intravenous Migraine Preventive Treatment Approved” from Migraine.com
The United States Food and Drug Administration (US FDA) has just approved Vyepti™ for the preventive treatment of migraine. Vyepti (eptinezumab-jjmr) will be the first intravenous (IV) preventive treatment on the market for migraine disease. It will be available...